Detection of matrix metallopeptidase-9-like proteins in Trypanosoma cruzi

Experimental Parasitology

Volumn 125, Issue 3, 2010, Pages 256-263

  Nogueira de Melo, Ana Cristina ^a   de Souza, Edilma Paraguai ^a   Elias, Camila Guarany Ramalho ^a   dos Santos, André Luis Souza ^a   Branquinha, Marta Helena ^a   d'Ávila Levy, Cláudia Masini ^b   dos Reis, Flávia Coelho Garcia ^a   Costa, Tatiana Ferreira Rocha ^a   de Araujo Lima, Ana Paula Cabral ^a   de Souza Pereira, Mirian Cláudia ^b   Meirelles, Maria Nazareth Leal ^b   Vermelho, Alane Beatriz ^a  

^a FEDERAL UNIVERSITY OF RIO DE JANEIRO   (Brazil)

^b INSTITUTO OSWALDO CRUZ   (Brazil)

Author keywords

Doxycycline; Matrix metallopeptidase 9; Peptidase; Trypanosoma cruzi

Indexed keywords

CELL ENZYME; CRUZIPAIN; CYSTEINE; DOXYCYCLINE; ENZYME ANTIBODY; GELATIN; GELATINASE B; METALLOPROTEINASE; POLYCLONAL ANTIBODY; POLYPEPTIDE;

AMASTIGOTE; ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; CELL SURFACE; CONTROLLED STUDY; CULTURE MEDIUM; ENZYME ACTIVITY; ENZYME ANALYSIS; ENZYME MECHANISM; ENZYME RELEASE; ENZYME SYNTHESIS; FLOW CYTOMETRY; IMMUNOPRECIPITATION; IN VITRO STUDY; MOUSE; NONHUMAN; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTEIN LOCALIZATION; TRYPANOSOMA CRUZI; TRYPOMASTIGOTE; WESTERN BLOTTING; ZYMOGRAPHY;

BLOTTING, WESTERN; ELECTROPHORESIS, POLYACRYLAMIDE GEL; FLOW CYTOMETRY; IMMUNOPRECIPITATION; MATRIX METALLOPROTEINASE 9; TRYPANOSOMA CRUZI;

TRYPANOSOMA CRUZI; TRYPANOSOMATIDAE;

EID: 77952582333     PISSN: 00144894     EISSN: 10902449     Source Type: Journal    
DOI: 10.1016/j.exppara.2010.01.023     Document Type: Article

References (48)

1. Aparício I.M., Scharfstein J., Lima A.P.C.A. A new cruzipain-mediated pathway of human cell invasion by Trypanosoma cruzi requires trypomastigote membranes. Infection and Immunity 2004, 77:5892-5902.
2. Barr S.C., Warner K.L., Kornreic B.G., Piscitelli J., Wolfe A., Benet L., McKerrow J.H. A cysteine protease inhibitor protects dogs from cardiac damage during infection by Trypanosoma cruzi. Antimicrobial Agents and Chemotherapy 2005, 49:5160-5161.
3. Bastos I.M., Grellier P., Martins N.F., Cadavid-Restrepo G., de Souza-Ault M.R., Augustyns K., Teixeira A.R., Schrével J., Maigret B., da Silveira J.F., Santana J.M. Molecular, functional and structural properties of the prolyl oligopeptidase of Trypanosoma cruzi (POP Tc80), which is required for parasite entry into mammalian cells. The Biochemical Journal 2005, 15:29-38.
4. Brack K., Doyle P.S., McKerrow J.H., Ellman J.A. Identification of a new class of nonpeptidic inhibitors of cruzain. The Journal of the American Chemical Society 2008, 130:6404-6410.
5. Bern C., Montgomery S.P., Herwaldt B.L., Rassi A.Jr., Marin-Neto J.A., Dantas R.O., Maguire J.H., Acquatella H., Morillo C., Kirchhoff L.V., Gilman R.H., Reyes P.A., Salvatella R., Moore A.C. Evaluation and treatment of Chagas disease in the United States: a systematic review. The Journal of the American Medical Association 2007, 298:2171-2181.
6. Bonaldo M.C., d'Escoffier L.N., Salles J.M., Goldenberg S. Characterization and expression of proteases during Trypanosoma cruzi metacyclogenesis. Experimental Parasitology 1991, 73:44-51.
7. Buache E., Garnotel R., Aubert D., Gillery P., Villena I. Reduced secretion and expression of gelatinase profile in Toxoplasma gondii-infected human monocytic cells. Biochemical and Biophysical Research Communications 2007, 359:298-303.
8. Burleigh B.A., Woolsey A.M. Cell signalling and Trypanosoma cruzi invasion. Cellular Microbiology 2002, 4:701-711.
9. Calvet C.M., Meuser M., Almeida D., Meirelles M.N., Pereira M.C. Trypanosoma cruzi-cardiomyocyte interaction: role of fibronectin in the recognition process and extracellular matrix expression in vitro and in vivo. Experimental Parasitology 2004, 107:20-30.
10. Cazzulo J.J. Proteinases of Trypanosoma cruzi: potential targets for the chemotherapy of Chagas' disease. Current Topics in Medical Chemistry 2002, 2:1261-1271.
11. Cockle J.A., Gopichandran N., Walker J.J., Levene M.I., Orsi N.M. Matrix metalloproteinases and their tissue inhibitors in preterm perinatal complications. Reproductive Science 2007, 14:629-645.
12. Costa J.D., Nogueira de Melo A.C., Vermelho A.B., Meirelles M.N., Porrozzi R. In vitro evidence for metallopeptidase participation in hepatocyte damage induced by Leishmania chagasi-infected macrophages. Acta Tropica 2008, 106:175-183.
13. Cuevas I.C., Cazzulo J.J., Sanchez D.O. Gp63 homologues in Trypanosoma cruzi: surface antigens with metalloprotease activity and a possible role in the host cell infection. Infection and Immunity 2003, 71:5739-5749.
14. Cuenca J., Martín-Sanz P., Álvarez-Barrientos A.M., Boscá L., Goren Nora Infiltration of inflammatory cells plays an important role in matrix metalloproteinase expression and activation in the heart during sepsis. The American Journal of Pathology 2006, 169:1567-1576.
15. d'Avila-Levy C.M., Souza R.F., Gomes R.C., Vermelho A.B., Branquinha M.H. A novel extracellular calcium-dependent cysteine proteinase from Crithidia deanei. Archives of Biochemistry and Biophysics 2003, 420:1-8.
16. Dietmann A., Helbok R., Lackner P., Issifou S., Lell B., Matsiegui P., Reindl M., Schmutzhard E., Kremsner P.G. Matrix metallopeptidases and their tissue inhibitors (TIMPs) in Plasmodium falciparum malaria: serum levels of TIMP-1 are associated with disease severity. The Journal of Infection Diseases 2008, 197:1614-1620.
17. Duschak V.G., Barboza M., García G.A., Lammel E.M., Couto A.S., Isola E.L.D. Novel cysteine proteinase in Trypanosoma cruzi metacyclogenesis. Parasitology 2006, 132:1-11.
18. Elias C.G.R., Pereira F.M., Silva B.A., Alviano C.S., Soares R.M.A., Santos A.L.S. Leishmanolysin (gp63 metalloproteinase)-like activity extracellularly released by Herpetomonas samuelpessoai. Parasitology 2006, 132:1-11.
19. Engel J.C., Doyle P.S., Hsieh I., McKerrow J.H. Cysteine protease inhibitors cure na experimental Trypanosoma cruzi infection. The Journal of Experimental Medicine 1998, 188:725-734.
20. Engman D.M., Leon J.S. Pathogenesis of Chagas heart disease: role of autoimmunity. Acta Tropica 2002, 81:123-132.
21. Ersfeld K., Barraclough H., Gull K. Evolutionary relationships and protein domain architecture in an expanded calpain superfamily in kinetoplastid parasites. The Journal of Molecular Evolution 2005, 61:742-757.
22. Galis Z.S., Khatri J.J. Matrix metalloproteinases in vascular remodeling and atherogenesis: the good, the bad, and the ugly. Circulation Research 2002, 90:251-262.
23. Garcia M.P., Nóbrega O.T., Teixeira A.R.L., Sousa M.V., Santana J.M. Characterisation of a Trypanosoma cruzi acidic 30 kDa cysteine protease. Molecular and Biochemical Parasitology 1998, 91:263-272.
24. Giese V., Dallagiovanna B., Marchini F.K., Pavoni D.P., Krieger M.A., Goldenberg S. Trypanosoma cruzi: a stage-specific calpain-like protein is induced after various kinds of stress. Memórias do Instituto Oswaldo Cruz 2008, 103:598-601.
25. Goll D.E., Thompson V.F., Li H., Wei W., Cong J. The calpain system. Physiological Reviews 2003, 83:731-801.
26. Gomis-Rüth F.X. Catalytic domain architecture of metzincin metalloproteases. The Journal of Biological Chemistry 2009, 284:15353-15357.
27. Gutierrez F.R., Lalu M.M., Mariano F.S., Milanezi C.M., Cena J., Gerlach R.F., Santos J.E., Torres-Dueñas D., Cunha F.Q., Schulz R., Silva J.S. Increased activities of cardiac matrix metalloproteinases matrix metalloproteinase (MMP)-2 and MMP-9 are associated with mortality during the acute phase of experimental Trypanosoma cruzi infection. The Journal of Infectious Diseases 2008, 197:1468-1476.
28. Hanemaaijer R., Visser H., Koolwijk P., Sorsa T., Salo T., Golub L.M., Van Hinsbergh V.W.M. Inhibition of MMP synthesis by doxycycline and chemically modified tetracyclines (CMTs) in human endothelial cells. Advances in Dental Research 1998, 12:114-118.
29. Heussen C., Dowdle E.B. Electrophoretic analysis of plasminogen activators in polyacrylamide gels containing sodium dodecyl sulphate and copolymerized substrates. Analytical Biochemistry 1980, 102:196-202.
30. Li J., Schwimmbeck P.L., Tschope C., Leschka S., Husmann L., Rutschow S., Reichenbach F., Noutsias M., Kobalz U., Poller W., Spillmann F., Zeichhardt H., Schultheiss H.P., Pauschinger M. Collagen degradation in a murine myocarditis model: relevance of matrix metalloproteinase in association with inflammatory induction. Cardiovascular Research 2002, 56:235-247.
31. Lowndes C.M., Bonaldo M.C., Thomaz N., Goldenberg S. Heterogeneity of metalloprotease expression in Trypanosoma cruzi. Parasitology 1996, 112:393-399.
32. Lowry O.H., Rosebrough N.J., Farr A.L., Randall R.J. Protein measurement with the Folin phenol reagent. The Journal of Biological Chemistry 1951, 19:264-275.
33. Malla N., Sjoli S., Winberg J.O., Hadler-Olsen E., Uhlin-Hansen L. Biological and pathobiological functions of gelatinase dimmers and complexes. Connect Tissue Research 2008, 49:180-184.
34. Meirelles M.N.L., Souto-Padrón T., De Souza W. Participation of the cell surface anionic sites in the interaction between Trypanosoma cruzi and macrophages. Journal of Submicroscopic Cytology and Pathology 1984, 16:533-545.
35. Nogueira de Melo A.C., Meirelles M.N.L., Porrozzi R., Costa J.D., Branquinha M.H., Vermelho A.B. Reduced activity of matrix metalloproteinase-9 in Trypanosoma cruzi infected mouse embryo hepatocyte cell. Hepatology Research 2004, 28:49-56.
36. Opdenakker G., Van Den Steel P.E., Van Damme J. Gelatinase B: a turner and amplifier of immune functions. Trends in Immunology 2001, 22:571-579.
37. Pinho R.T., Beltramini L.M., Alves C.R., De-Simone S.G. Trypanosoma cruzi: isolation and characterization of aspartyl proteases. Experimental Parasitology 2009, 122:128-133.
38. Rossi M.A. Connective tissue skeleton in the normal left ventricle and in hypertensive left ventricular hypertrophy and chronic chagasic myocarditis. Medical Science Monitor 2001, 7:820-832.
39. Rutschow S., Li J., Schultheiss H.P., Pauschinger M. Myocardial proteases and matrix remodeling in inflammatory heart disease. Cardiovascular Research 2006, 69:646-656.
40. Sangenito L.S., Ennes-Vidal V., Marinho F.A., Da Mota F.F., Santos A.L.S., d'Avila-Levy C.M., Branquinha M.H. Arrested growth of Trypanosoma cruzi by the calpain inhibitor MDL28170 and detection of calpain homologues in epimastigote forms. Parasitology 2009, 136:433-441.
41. Scharfstein J., Schmitz V., Morandi V., Capella M.M., Lima A.P., Morrot A., Juliano L., Muller-Esterl W. Host cell invasion by Trypanosoma cruzi is potentiated by activation of bradykinin B(2) receptors. The Journal of Experimental Medicine 2000, 192:1289-1300.
42. Souto-Padrón T., Campetella O.E., Cazzulo J.J., De Souza W. Cysteine proteinase in Trypanosoma cruzi: immunocytochemical localization and involvement in parasite-host cell interaction. Journal of Cell Science 1990, 96:485-490.
43. Spinale F.G. Myocardial matrix remodeling and the matrix metalloproteinases: influence on cardiac form and function. Physiological Reviews 2007, 87:1285-1342.
44. Van den Steen P.E., Dubois B., Nelissen I., Rudd P.M., Dwek R.A., Opdenakker G. Biochemistry and molecular biology of gelatinase B or matrix metalloproteinase-9 (MMP-9). Critical Reviews in Biochemistry and Molecular Biology 2002, 37:375-536.
45. Vermelho A.B., Giovanni-De-Simone S., d'Avila-Levy C.M., Santos A.L.S., Nogueira de Melo A.C., Silva F.P., Bon E.P., Branquinha M.H. Trypanosomatidae: peptidases and drugs development. Current Enzyme Inhibition 2007, 3:19-48.
46. Xu L., Jiang W., Ma T., Qiu P., Hou J., Huang Y., Chen J., Yan G. Expression, purification and molecular modeling of recombinant fibrinogenase [IV], a metalloproteinase from Deinakistrodon acutus venom. Toxicon 2006, 47:241-248.
47. Yoshida N. Molecular mechanisms of Trypanosoma cruzi infection by oral route. Memórias do Instituto Oswaldo Cruz 2009, 104:101-107.
48. WHO - World Health Organization, 2006. Strategic and technical meeting on intensified control of neglected tropical diseases. In: Proceedings of the Report of an International Workshop. Berlin, April 18-20, 2005, WHO/CDS/NTD/2006.1. Available from: <> (accessed in December 2006). http://www.who.int/neglecteddiseases/en/.